ArticleColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland2026
Quality of life assessment for colorectal cancer follow-up: A latent profile analysis of EORTC measures.
Article in Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality of life assessment for colorectal cancer follow-up: A latent profile analysis of EORTC measures.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimTo identify distinct health-related quality of life (HRQoL) profiles among colorectal cancer (CRC) patients using patient-reported outcome measures (PROMs), with the aim of informing more personalised follow-up strategies.
methodsBaseline HRQoL data from CRC patients enrolled in the FUTURE-primary study, a multicentre implementation study on home-based follow-up, were analysed. Patients completed the EORTC QLQ-C30 and QLQ-CR29 questionnaires. Aggregated symptom and function scales were developed using factor analysis and expert consensus. Latent profile analysis (LPA) was applied to identify subgroups based on PROM responses. Model selection was guided by the Bayesian Information Criterion (BIC), entropy, average posterior probabilities (AvePP), class sizes, clinical interpretability, and additional sensitivity and stability analyses.
resultsThree HRQoL profiles were identified: low HRQoL (n = 62), intermediate HRQoL (n = 95), and high HRQoL (n = 42). The profiles followed a gradient-like pattern, with consistently high, moderate, or low scores across symptom burden and functional outcomes. Classification quality was high, as indicated by high entropy (>0.93) and average posterior probabilities (>0.96), although profile assignment should be interpreted probabilistically.
conclusionThis study highlights variation in HRQoL among CRC patients. LPA identified three profiles that primarily reflected differences in overall symptom burden and functioning. These profiles may provide a preliminary framework for describing differences in supportive care needs, but their clinical applicability for tailoring follow-up or allocating care resources requires longitudinal validation. IMPLICATIONS FOR CANCER SURVIVORS: Identifying HRQoL profiles may support more personalised follow-up, ensuring targeted care for those with higher symptom burden and lower functional scores, while reducing unnecessary interventions for others.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.